Limits...
Quality of life and disease understanding: impact of attending a patient-centered cancer symposium.

Padrnos L, Dueck AC, Scherber R, Glassley P, Stigge R, Northfelt D, Mikhael J, Aguirre A, Bennett RM, Mesa RA - Cancer Med (2015)

Bottom Line: Most respondents reported at least "quite a bit" of understanding regarding treatment options, screening modalities, symptomatology, and cancer-related side effects.At 3 months, there was improvement in understanding (12 of 14 areas of self-reported knowledge especially regarding nutrition, and stress/fatigue management).However, no significant change was seen in QLQ-C30 functioning, fatigue, pain, or insomnia.

View Article: PubMed Central - PubMed

Affiliation: Internal Medicine Residency Program, Mayo Clinic, Scottsdale, Arizona.

No MeSH data available.


Related in: MedlinePlus

Number of specific cancer diagnoses reported in pre-intervention participants. N = 158 individuals.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4472202&req=5

fig02: Number of specific cancer diagnoses reported in pre-intervention participants. N = 158 individuals.

Mentions: The median age was 67.5 years with a range of 30–86 years. Males and females were equally represented in the pre-survey population (Table3). Cancer disease type included 40% hematologic malignancies (n = 64), 23% breast cancer (n = 36), 23% prostate cancer (n = 36), and 17% other (see Fig. 2 and Fig.3). The majority of respondents were greater than 1 year from cancer diagnosis (76%), with 40% greater than 3 years from diagnosis. Most participants had undergone treatment of some sort by the time of the symposium.


Quality of life and disease understanding: impact of attending a patient-centered cancer symposium.

Padrnos L, Dueck AC, Scherber R, Glassley P, Stigge R, Northfelt D, Mikhael J, Aguirre A, Bennett RM, Mesa RA - Cancer Med (2015)

Number of specific cancer diagnoses reported in pre-intervention participants. N = 158 individuals.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4472202&req=5

fig02: Number of specific cancer diagnoses reported in pre-intervention participants. N = 158 individuals.
Mentions: The median age was 67.5 years with a range of 30–86 years. Males and females were equally represented in the pre-survey population (Table3). Cancer disease type included 40% hematologic malignancies (n = 64), 23% breast cancer (n = 36), 23% prostate cancer (n = 36), and 17% other (see Fig. 2 and Fig.3). The majority of respondents were greater than 1 year from cancer diagnosis (76%), with 40% greater than 3 years from diagnosis. Most participants had undergone treatment of some sort by the time of the symposium.

Bottom Line: Most respondents reported at least "quite a bit" of understanding regarding treatment options, screening modalities, symptomatology, and cancer-related side effects.At 3 months, there was improvement in understanding (12 of 14 areas of self-reported knowledge especially regarding nutrition, and stress/fatigue management).However, no significant change was seen in QLQ-C30 functioning, fatigue, pain, or insomnia.

View Article: PubMed Central - PubMed

Affiliation: Internal Medicine Residency Program, Mayo Clinic, Scottsdale, Arizona.

No MeSH data available.


Related in: MedlinePlus